• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.33 número5

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.33 número5" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.33 número5".

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Several aspects were mentioned and a presentation by the representative of the University of Granada, Spain responsible for SCImago, emphasized the importance of Brazil and suggested ado[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... The diagnosis of WHIM syndrome was mainly based on the patient's clinical background with recurrent infections and severe chronic neutropenia and on specific laboratorial findings includ[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Immediate transfusion incidents occur during transfusion or within 24 hours after and include: acute hemolytic transfusion reactions (AHTR), febrile non-hemolytic reactions, allergic rea[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... trait presented with significantly higher levels (p-value < 0.05) of the following variables compared to controls: reticulocytes (percentage and number), medium fluorescence reticuloc[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... However, our work incorporates one new parameter (red cell distribution width), and provides values that better reflect the current conditions of the majority of the adult population of [r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Deficiency of this enzyme leads to the accumulation of iron in various organs; aceruloplasminemia is usually characterized by diabetes, retinal degeneration and neurological disorders.. [r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... 47. Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG. American Society of Transplantation Infectious Diseases Community of Practice. Interlaboratory comparison of Epstein- Barr virus viral load assays. ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Ig is obtained by processing plasma; methods, in particular, techniques to reduce plasma viral loads have been evolving over the years and include: pasteurization, solvent/ detergent tre[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Method: Here we describe a one-day workshop model conducted by the Chronic Graft-versus-Host Disease Brazil-Seattle Consortium Study Group to train investigators interested in participa[r] ... See full document

9

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... The probability of EFS at 10 years for the whole group was 32.5% (95% CI: 17.9-48.1%). Of the 33 who entered into remission, 20 children (60.6%) had at least one reactivation episode. When only patients with ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Conclusions: In order to improve the quality of blood and reduce the residual risk of HIV transmission in blood banks, it is necessary to know the profiles of donors who most frequently[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Although CUE considers direct and indirect markers of risk associated with sexually or intravenous transmissible diseases, this study also included Chagas' disease serology, because this[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... The prognosis for this group of patients is usually excellent although approximately 30% of the patients will experience disease reactivation that continue to respond to treatment.. As n[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... 1. Tavares RC, Silva MM, Bouzas LF, Rodrigues MC, Vigorito AC, Funke V, et al. Brazilian workshop model for training of investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 ... See full document

1

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Blood centers should explain the risks of transfusion-transmitted infectious diseases to blood donors who repeatedly use the CUE option or report post-donation information to exclude the[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... Resolution number 57 of the Agência Nacional de Vigilância Sanitária (ANVISA) defines hemovigilance as "a set of surveillance procedures covering the cycle of blood, from the donatio[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... 6. Seber A, Bonfim CM, Daudt LE, Gouveia RV, Ginani VC, Mauad M, et al . Indicações de transplante de células-tronco hematopoéticas em pediatria: consenso apresentado no I Encontro de Diretrizes Brasileiras em ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número5

Rev. Bras. Hematol. Hemoter. vol.33 número5

... It will be interesting in future studies, to better characterize the lower CD4/CD8 ratio in elderly men, to investigate if CD* T cell homeostatic proliferation occurs in this population [r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número6

Rev. Bras. Hematol. Hemoter. vol.33 número6

... The myelodysplastic syndromes (MDS), acute myeloid leukemias (AML) and secondary myeloproliferative syndromes (MPS) constitute a group of myeloid neoplasias (MNs) which result from expos[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.33 número6

Rev. Bras. Hematol. Hemoter. vol.33 número6

... The secretor gene that encodes for 2-alpha-L-fucosyltransferase and the ABO blood grouping system that encodes for glycosyltransferases, act in concert to build-up oligosaccharide struct[r] ... See full document

2

Show all 10000 documents...